A study evaluating efficacy and tolerability of Panitumumab in patients with metastatic colorectal cancer.
Latest Information Update: 07 Jun 2017
At a glance
- Drugs Panitumumab (Primary) ; Bevacizumab
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2017 New trial record
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology